Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01905540 · ClinicalTrials.gov registry record · Phase 1
A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT01905540 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 28 participants.
The verdict
NCT01905540, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will evaluate the relative bioavailability of the new SSP-004184SS capsule formulation compared to the original SSP-004184AQ drug plus excipients formulation.
Interventions
- DRUG SSP-004184SS
- DRUG SSP-004184AQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-08-05 |
| Est. Completion | 2013-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01905540
The ClinicalTrials.gov registry entry for NCT01905540 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SSP-004184SS is the first listed.
NCT01905540 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01905540 about?
NCT01905540 is a clinical study titled "A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)". This study will evaluate the relative bioavailability of the new SSP-004184SS capsule formulation compared to the original SSP-004184AQ drug plus excipients formulation.
What is the current status of trial NCT01905540?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2013-08-05. Estimated completion is 2013-09-20.
What interventions are being tested in trial NCT01905540?
The interventions under investigation include: SSP-004184SS (DRUG), SSP-004184AQ (DRUG).
Who is sponsoring clinical trial NCT01905540?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.